K-ras mutations in tissue and stool samples from patients with pancreatic cancer and chronic pancreatitis

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Langenbeck's archives of surgery (Print)

• Publication date

  1999-03-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s004230050189PMID 10328172
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tumor-suppressive pathways in pancreatic carcinoma.

  1997cited by this paper
• Detection of K‐ras gene mutations at codon 12 in the pancreatic juice of patients with intraductal papillary mucinous tumors of the pancreas

  1997cited by this paper
• Analysis of K-ras oncogene mutations in chronic pancreatitis with ductal hyperplasia.

  1997cited by this paper
• Molecular genetics of malignant insulinoma.

  1996cited by this paper
• DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1

  1996cited by this paper
• Clinical significance of K-ras oncogene activation in ampullary neoplasms.

  1996cited by this paper
• Analysis of K-ras gene mutation in hyperplastic duct cells of the pancreas without pancreatic disease.

  1996cited by this paper
• Detection of K‐ras mutations in stools of patients with colorectal cancer by mutant‐enriched PCR

  1996cited by this paper
• K‐ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction

  1996cited by this paper
• Diagnosis of pancreatic cancer by K-ras point mutation and cytology of pancreatic juice.

  1996cited by this paper
• A microplate assay for K-ras genotyping.

  1996cited by this paper
• Identification of subjects at risk for colorectal carcinoma through a test based on K-ras determination in the stool.

  1996cited by this paper
• Long‐Term Survival After Resection for Ductal Adenocarcinoma of the Pancreas Is It Really Improving?

  1995cited by this paper
• Detection of K-ras mutations in DNAs isolated from feces of patients with colorectal tumors by mutant-allele-specific amplification (MASA).

  1995cited by this paper
• Aberrant crypt foci and K-ras mutations: earliest recognized players or innocent bystanders in colon carcinogenesis?

  1995cited by this paper
• Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis.

  1995cited by this paper
• Pancreatitis and the Risk of Pancreatic Cancer

  1995cited by this paper
• Molecular genetics of dysplasia in ulcerative colitis.

  1995cited by this paper
• Tumor Markers in the Diagnosis, Monitoring and Therapy of Pancreatic Cancer: State of the Art

  1995cited by this paper
• Detection of c-Ki-ras gene codon 12 mutations from pancreatic duct brushings in the diagnosis of pancreatic tumours.

  1995cited by this paper
• Identification of K-ras Mutations in Pancreatic Juice in the Early Diagnosis of Pancreatic Cancer

  1995cited by this paper
• Detection of c-Ki-ras mutations in faecal samples from sporadic colorectal cancer patients.

  1995cited by this paper
• Ki-ras mutations in pancreatic secretions and aspirates from two patients without pancreatic cancer.

  1994cited by this paper
• Detection of K-ras mutations in mucinous pancreatic duct hyperplasia from a patient with a family history of pancreatic carcinoma.

  1994cited by this paper
• K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions.

  1994cited by this paper
• Detection of ki-ras mutation in nonneoplastic mucosa of Japanese patients with colorectal cancers.

  1994cited by this paper
• Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.

  1994cited by this paper
• Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

  1994cited by this paper
• Pancreatic cancer in europe: Ki‐ras gene mutation pattern shows geographical differences

  1994cited by this paper
• Detection of k-ras mutation in normal and malignant colonic tissues by an enriched PCR method.

  1994cited by this paper
• ras‐family gene mutations in neoplasia of the ampulla of vater

  1994cited by this paper
• The role of Ras mutation in pancreatic cancer, precancerous lesions, and chronic pancreatitis.

  1993cited by this paper
• K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.

  1993cited by this paper
• Pancreatitis and the risk of pancreatic cancer.

  1993cited by this paper
• Frequent c-Ki-ras oncogene activation in mucous cell hyperplasias of pancreas suffering from chronic inflammation.

  1993cited by this paper
• Pancreatitis and the risk of pancreatic cancer

  1993cited by this paper
• Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors.

  1992cited by this paper
• Clinical application of ras gene mutation for diagnosis of pancreatic adenocarcinoma.

  1991cited by this paper
• Detection of K-ras mutations in pancreatic and hepatic neoplasms by non-isotopic mismatched polymerase chain reaction.

  1991cited by this paper
• Mutations in the Kirsten-ras oncogene are common but lack correlation with prognosis and tumor stage in human pancreatic carcinoma.

  1991cited by this paper
• Analysis of ras gene mutations in biliary and pancreatic tumors by polymerase chain reaction and direct sequencing

  1990cited by this paper

• Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool

  2022cites this paper
• Investigating the potential of photodynamic and sonodynamic therapy for the treatment of pancreatic cancer

  2018cites this paper
• Liquid biopsies for management of pancreatic cancer

  2018cites this paper
• IDENTIFYING THE IMMUNE RELATED METABOLIC PROPERTIES OF PANCREATIC CANCER USING NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY AND DYNAMIC MAGNETIC RESONANCE SPECTROSCOPIC IMAGING WITH HYPERPOLARIZED PYRUVATE

  2017cites this paper
• Clinical applications of circulating tumor DNA and circulating tumor cells in pancreatic cancer

  2016cites this paper
• Identification of dysregulated pathways associated with pancreatic cancer by survival analysis.

  2015cites this paper
• K-ras Mutational Status in Cytohistological Tissue as a Molecular Marker for the Diagnosis of Pancreatic Cancer: A Systematic Review and Meta-Analysis

  2014cites this paper
• Low Frequency of KRAS Mutation in Pancreatic Ductal Adenocarcinomas in Korean Patients and Its Prognostic Value

  2014cites this paper
• Lung Cancer and Mesothelioma

  2014cites this paper
• Diagnostic accuracy of K-ras mutation for pancreatic carcinoma: a meta-analysis.

  2013cites this paper
• EGFR and KRAS Mutational Analysis and Their Correlation to Survival in Pancreatic and Periampullary Cancer

  2012cites this paper
• How useful is it clinically to analyse the K‐ras mutational status for the diagnosis of exocrine pancreatic cancer? A systematic review and meta‐analysis

  2011cites this paper
• Clinical validity of detecting K-ras mutations for the diagnosis of exocrine pancreatic cancer: a prospective study in a clinically-relevant spectrum of patients

  2011cites this paper
• Toxicology of the Exocrine Pancreas

  2009cites this paper
• Is endoscopic ultrasound "sound" for pancreatic cancer screening?

  2009cites this paper
• Surgical and Adjuvant Treatment of Pancreatic Cancer

  2008cites this paper
• Genetic and Epigenetic Alterations of Familial Pancreatic Cancers

  2008cites this paper
• Molecular markers of pancreatic cancer: development and clinical relevance

  2008cites this paper
• Molecular diagnosis in pancreatic cancer

  2008cites this paper
• Stool testing for the early detection of pancreatic cancer: rationale and current evidence

  2008cites this paper
• Molecular Detection of Occult Tumor Cells

  2007cites this paper
• A homogeneous assay for analysis of FMR1 promoter methylation in patients with fragile X syndrome.

  2007cites this paper
• Mutant-enriched PCR and allele-specific hybridization reaction to detect K-ras mutations in stool DNA: high prevalence in a large sample of older adults.

  2007cites this paper
• Detection of Ki-ras mutations in tissue and plasma samples of patients with pancreatic cancer using PNA-mediated PCR clamping and hybridisation probes

  2005cites this paper
• Early detection markers in Pancreas Cancer

  2005cites this paper
• Pancreatic cancer

  2004cites this paper
• Values of mutations of K-ras oncogene at codon 12 in detection of pancreatic cancer: 15-year experience.

  2004cites this paper
• Detection of K-ras point mutation and telomerase activity during endoscopic retrograde cholangiopancreatography in diagnosis of pancreatic cancer.

  2004cites this paper
• Immunohistochemical Analysis of Biliary Tract Lesions

  2004cites this paper
• Detection of oncogenes in chronic pancreatitis.

  2003cites this paper
• Gastrointestinal tract cancer screening using fecal carcinoembryonic antigen.

  2003cites this paper
• Pancreatic cancer since Halsted: how far have we come and where are we going?

  2003cites this paper
• Frequent detection of K-ras mutation in stool samples of colorectal carcinoma patients after improved DNA extraction: comparison with tissue samples.

  2002cites this paper
• Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA

  2002cites this paper
• Low sensitivity of the ki-ras polymerase chain reaction for diagnosing pancreatic cancer from pancreatic juice and bile: a multicenter prospective trial.

  2002cites this paper
• Pancreatic Cancer

  2002cites this paper
• The Molecular Biology of Pancreatic Cancer

  2002cites this paper
• Molecular Markers as a Tool for the Early Diagnosis of Pancreatic Cancer

  2002cites this paper
• Differentiation of Chronic Pancreatitis from Pancreatic Cancer: Recent Advances in Molecular Diagnosis

  2001cites this paper
• Hereditary Chronic Pancreatitis: Implications for Surgical Treatment and Follow-Up

  2001cites this paper
• Molecular Diagnosis of Early Pancreatic Ductal Adenocarcinoma in High-Risk Patients

  2001cites this paper
• Screening for early pancreatic ductal adenocarcinoma in hereditary pancreatitis.

  2000cites this paper
• At the Crossroads of Inflammation and Tumorigenesis

  1999cites this paper